Eledon Pharmaceuticals Inc. (ELDN) is scheduled to make presentations at the American Transplant Congress (ATC) taking place in Boston, Massachusetts, from June 20-24, 2026.
The company will hold a conference call on June 22, 2026, at 8:00 a.m. Eastern Time to discuss updated data from the Phase 2 BESTOW clinical trial and new long-term data from the Phase 2 BESTOW extension study presented at the American Transplant Congress.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Prabha Kurup
For comments and feedback: contact editorial@rttnews.com